User profiles for "author:Yaron Niv"

Yaron Niv

Clinical Professor Internal Medicine Ariel University
Verified email at ariel.ac.il
Cited by 15722

Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers

L Agréus, EJ Kuipers, L Kupcinskas… - Scandinavian journal …, 2012 - Taylor & Francis
Background and aims. Atrophic gastritis (AG) results most often from Helicobacter pylori (H.
pylori) infection. AG is the most important single risk condition for gastric cancer that often …

Epidemiology of Helicobacter pylori infection

O Sjomina, J Pavlova, Y Niv, M Leja - Helicobacter, 2018 - Wiley Online Library
This review provides the most recent data concerning the epidemiology of Helicobacter
pylori infection. Overall, the trend of declining prevalence of H. pylori infection is continuing …

Mucin function in inflammatory bowel disease: an update

D Boltin, TT Perets, A Vilkin, Y Niv - Journal of clinical …, 2013 - journals.lww.com
MUC2 is the primary component of the mucin barrier that separates the intestinal microbiota
and the intestinal epithelium. This mucous barrier is affected by both luminal/microbial …

A quantitative immunochemical fecal occult blood test for colorectal neoplasia

Z Levi, P Rozen, R Hazazi, A Vilkin… - Annals of internal …, 2007 - acpjournals.org
Background: Guaiac-based fecal occult blood tests (FOBTs) for colorectal cancer screening
are not specific for human hemoglobin and have low sensitivity. Automated-development …

Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials

BG Feagan, WJ Sandborn, U Mittmann, S Bar-Meir… - Jama, 2008 - jamanetwork.com
Context Maintenance therapy for Crohn disease features the use of immunosuppressive
drugs, which are associated with an increased risk of infection. Identification of safe and …

Comparative effectiveness of multiple different first-line treatment regimens for Helicobacter pylori infection: a network meta-analysis

T Rokkas, JP Gisbert, P Malfertheiner, Y Niv… - Gastroenterology, 2021 - Elsevier
Background & Aims A number of double, triple, and quadruple therapies have been
proposed as first-line empiric treatments for Helicobacter pylori infection. However …

Assessment and validation of the new capsule endoscopy Crohn's disease activity index (CECDAI)

E Gal, A Geller, G Fraser, Z Levi, Y Niv - Digestive diseases and sciences, 2008 - Springer
Background Capsule endoscopy is a relatively new imaging tool for the detection of small
bowel pathology. The assessment of the severity of Crohn's disease by capsule endoscopy …

European Registry on Helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 …

OP Nyssen, D Bordin, B Tepes, Á Pérez-Aisa, D Vaira… - Gut, 2021 - gut.bmj.com
Objective The best approach for Helicobacter pylori management remains unclear. An audit
process is essential to ensure clinical practice is aligned with best standards of care. Design …

Relationship between Helicobacter pylori CagA status and colorectal cancer

H Shmuely, D Passaro, A Figer, Y Niv, S Pitlik… - The American journal of …, 2001 - Elsevier
OBJECTIVES: Infection with Helicobacter pylori, particularly with strains positive for CagA
protein, increases the risk of gastric adenocarcinoma. Few studies have explored the …

Estrogen receptor beta as target for colorectal cancer prevention

C Williams, A DiLeo, Y Niv, JÅ Gustafsson - Cancer letters, 2016 - Elsevier
Colorectal cancer (CRC) is a leading cause of death in the United States. Despite its slow
development and the capacity for early diagnosis, current preventive approaches are not …